In 2022, the estimated value of the global bone graft fixation system market was $2.85 Billion. By 2032, that number is expected to rise to US$5.49 Billion at a CAGR of 6.2%.
The rising prevalence of degenerative bone and joint diseases such as osteoarthritis and osteoporosis and fracture patient population from frequent falls will set the tone for bone graft fixation system market growth.
A bone graft fixation system is a tool used during a treatment to repair and transplant broken bones or damaged joints. For bone tissue to regenerate, it needs a piece of bone or a substance like bone. A gap is created and the graft material is put within the bone to initiate the regeneration process in bones.
Depending on the type, location, and severity of the fracture, different types of bone graft fixation systems are available. Dental implants, fibular fractures, joint fusion, and bone fracture healing all use the bone graft fixation technique. Osteogenesis, osteoinduction, osteoconduction, and osteopromotion are all assisted by the bone graft fixation system.
The key factors driving the growth of the bone graft fixation system market include the following:
The introduction of synthetic grafts that are biocompatible
| Attributes | Details |
|---|---|
| Market Value (2022) | US$ 2.85 Billion |
| Market Value (2032) | US$ 5.49 Billion |
| CAGR | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2022, more than 40.0% of the market revenue came from North America. The regional market is growing due to several factors, the most important of which are the increasing number of people aware of the commercially available novel products, the presence of a well-developed healthcare framework, and the more significant healthcare expenditure of 16.9%. Rising trauma and orthopedic disease rates in the USA have led to a greater demand for bone graft fixation systems and substitutes in the American bone graft fixation system market, which in turn leads North America and the world.
Profitable expansion is predicted for the Asia-Pacific region over the projected horizon. Rising interest in international medical travel and supportive policy actions have contributed to this expansion. However, in a few countries, strict regulatory constraints limit implementation. For example, the Korean Food and Drug Administration must give its stamp of approval before a product may be sold in South Korea (KFDA). Japan's rigorous regulatory approach makes it difficult for international companies to set up shop there. With the recent 2019 approval of DBM in Japan, however, the allograft market in Asia and the Pacific is expected to develop at a healthy rate over the next decade.
Over 60.0% of total sales of bone graft fixation systems in 2021 came from the spinal fusion market. The market is segmented into the following subsets based on end use: long bone, spinal fusion, foot & ankle, joint repair, craniomaxillofacial, and dentistry. The increasing adoption of bone graft fixation systems for spondylosyndesis is mostly responsible for the expansion. In addition, the growing elderly population, which is more likely to suffer from orthopaedic problems, is driving up demand for corrective surgical therapy, which is forecasted to enhance the market soon. The percentage of people aged 60 and above is projected to increase from 12% in 2015 to 22% in 2050, according to the World Health Organization.
The rising prevalence of knee and hip replacement surgeries bodes well for joint reconstruction over the anticipated period. Total knee replacement surgeries are expected to increase by 673%, reaching 3.5 million treatments yearly by 2030, as reported by the centre for orthopaedic and neurological care and research. Market experts predict that the long bone subsector will expand rapidly in the next years. The adoption of bone graft fixation systems and substitutes in long bone procedures has increased in recent years, in part due to the prevalence of injuries and trauma to the extremities as a result of traffic accidents and sports injuries. Baxter, Stryker, and Medtronic are three major companies in the bone graft fixation system market.
Principal Consultant
A significant patient population is served by the use of the bone graft fixation system by general orthodontists, orthopedics, and spinal fusion specialists. The market for bone graft fixation systems is expected to grow over the next years as a result of factors including a rise in the number of surgeries performed on patients, an aging population, and improvements in graft design.
The main factors anticipated to propel the growth of the bone graft fixation system market over the forecast period include an increase in the number of patients with bone abnormalities, an increase in healthcare expenditure, an increase in the number of trauma cases, and an expansion of the product portfolio of bone graft fixation system. Additionally, during the forecast period, the market for bone grafts and substitutes is anticipated to be driven by the increasing need for dental bone grafts.
Geographically, the global bone graft fixation system market is segmented into seven major regions which include North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Among these regions, North America is expected to hold a major share of the global bone graft fixation system market, followed by Europe.
Rising healthcare expenditure and the availability of a well-resourced healthcare system propel the demand for bone graft fixation systems. Furthermore, orthopedic disease as well as an increasing number of trauma-related injuries are playing an important role in the market development.
During the projected period, Europe is anticipated to see profitable growth. The factors like growing geriatric population, high rates of osteoporosis, osteoarthritis, and other bone ailments are boosting market expansion in the bone graft fixation system market. Due to better results and greater awareness, the bone graft fixation system market is anticipated to grow over the projected period, in the Asian region and the Middle East, and Africa.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players operating in the bone graft fixation system industry are DePuy Synthesis, Inc, Smith & Nephew, Auxein Medical, Stryker Corporation, Baumer S.A., Mikai S.p.A, Biocomposites, Zimed Medikal, Zimmer Biomet, Acumed, Medtronic, Orthofix Holdings, Inc, Nuvasive, Inc., Allograft Bone Chips and other.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 6.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Product Type, Material, Application, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Players | DePuy Synthesis, Inc; Smith & Nephew; Auxein Medical; Stryker Corporation; Baumer S.A.; Mikai S.p.A; Biocomposites; Zimed Medikal; Zimmer Biomet; Acumed; Medtronic; Orthofix Holdings, Inc; Nuvasive, Inc.; Allograft Bone Chips |
| Customization | Available Upon Request |
The global bone graft fixation system market is anticipated to register a CAGR of 6.2% during the forecast period.
The bone graft fixation system market is projected to be about US$ 5.49 Billion by the end of the year 2032.
Explore Healthcare Insights
View Reports
Bone Graft Fixation System Market
